Telomere length predicts progression and overall survival in chronic lymphocytic leukemia: data from the UK LRF CLL4 trial. (Q30986040)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26256637%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

title

Telomere length predicts progression and overall survival in chronic lymphocytic leukemia: data from the UK LRF CLL4 trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26256637%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

0 references

0 references

chronic lymphocytic leukemia

1 reference

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26256637%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Matthew J Rose-Zerilli

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26256637%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Tatjana Stankovic

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26256637%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Duncan Baird

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26256637%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

author name string

J C Strefford

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26256637%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

L Kadalayil

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26256637%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

J Forster

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26256637%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

A Parker

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26256637%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

T T Lin

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26256637%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

N Heppel

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26256637%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

K Norris

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26256637%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

A Gardiner

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26256637%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Z Davies

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26256637%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

D Gonzalez de Castro

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26256637%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

M Else

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26256637%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

A J Steele

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26256637%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

H Parker

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26256637%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

C Pepper

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26256637%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

C Fegan

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26256637%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

D G Oscier

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26256637%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

D Catovsky

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26256637%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

publication date

10 August 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26256637%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26256637%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26256637%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26256637%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

page(s)

2411-2414

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26256637%20AND%20SRC:MED&resulttype=core&format=json

ATM mutation rather than BIRC3 deletion and/or mutation predicts reduced survival in 11q-deleted chronic lymphocytic leukemia: data from the UK LRF CLL4 trial.

21 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4676082

The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4676082

Telomere dysfunction and its role in haematological cancer.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4676082

Mutational status of the TP53 gene as a predictor of response and survival in patients with chronic lymphocytic leukemia: results from the LRF CLL4 trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4676082

Prognostic factors identified three risk groups in the LRF CLL4 trial, independent of treatment allocation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4676082

Telomere length is an independent predictor of survival, treatment requirement and Richter's syndrome transformation in chronic lymphocytic leukemia.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4676082

Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4676082

Telomere dysfunction and fusion during the progression of chronic lymphocytic leukemia: evidence for a telomere crisis

21 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FLEU.2015.217

Short telomere length is associated with NOTCH1/SF3B1/TP53 aberrations and poor outcome in newly diagnosed chronic lymphocytic leukemia patients.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FLEU.2015.217

Biallelic ATM inactivation significantly reduces survival in patients treated on the United Kingdom Leukemia Research Fund Chronic Lymphocytic Leukemia 4 trial.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FLEU.2015.217

Telomere dysfunction accurately predicts clinical outcome in chronic lymphocytic leukaemia, even in patients with early stage disease

21 January 2018

1 reference

12 December 2020

Telomeres and prognosis in patients with chronic lymphocytic leukaemia

1 reference

12 December 2020

Telomere length as a prognostic parameter in chronic lymphocytic leukemia with special reference to VH gene mutation status

1 reference

12 December 2020

Short telomeres are associated with genetic complexity, high-risk genomic aberrations, and short survival in chronic lymphocytic leukemia

1 reference

12 December 2020

Identifiers

DOI

10.1038/LEU.2015.217

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26256637%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

21 February 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26256637%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26256637%20AND%20SRC:MED&resulttype=core&format=json